Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efavirenz and Ritonavir on Human Brian P-Glycoprotein (dLOP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01668147
First received: July 30, 2012
Last updated: October 31, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)